These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 16773383)

  • 21. [Chronic sacral bilateral neuromodulation. Using a minimal invasive implantation technique in patients with disorders of bladder function].
    Braun PM; Seif C; Scheepe JR; Martinez Portillo FJ; Bross S; Alken P; Jünemann KP
    Urologe A; 2002 Jan; 41(1):44-7. PubMed ID: 11963774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detailed Investigation of Bladder Diary Parameters During Sacral Neuromodulation in Patients With Overactive Symptoms.
    Van de Borne S; Tilborghs S; Vaganée D; Vermandel A; De Wachter S
    Neuromodulation; 2023 Dec; 26(8):1831-1835. PubMed ID: 36266179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new technique of laparoscopic implantation of stimulation electrode to the pudendal nerve for treatment of refractory fecal incontinence and/or overactive bladder with urinary incontinence.
    Possover M
    J Minim Invasive Gynecol; 2014; 21(5):729. PubMed ID: 24509291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of sacral neuromodulation in male patients with overactive bladder, chronic pelvic pain, and fecal incontinence.
    Ferreira R; Alwashmi E; Otis-Chapados S; Bhojani N; Zorn KC; Chughtai B; Elterman DS
    Can J Urol; 2024 Aug; 31(4):11943-11949. PubMed ID: 39217518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive impairment does not impact sacral neuromodulation implant rates for overactive bladder.
    Zillioux J; Lewis KC; Hettel D; Goldman HB; Vasavada SP; Gill BC
    Neurourol Urodyn; 2023 Mar; 42(3):623-630. PubMed ID: 36701189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term safety of sacral nerve modulation in medicare beneficiaries.
    Chughtai B; Sedrakyan A; Isaacs A; Lee R; Te A; Kaplan S
    Neurourol Urodyn; 2015 Sep; 34(7):659-63. PubMed ID: 25066920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new minimally invasive procedure for pudendal nerve stimulation to treat neurogenic bladder: description of the method and preliminary data.
    Spinelli M; Malaguti S; Giardiello G; Lazzeri M; Tarantola J; Van Den Hombergh U
    Neurourol Urodyn; 2005; 24(4):305-9. PubMed ID: 15977260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary analysis of stimulation parameters for sacral neuromodulation in different indications: a multicenter retrospective cohort study from China.
    Meng L; Yan Z; Wang X; Zhang Y; Zhu Z; Zhu W; Ling Q; Sun X; Gu Y; Lv J; Li Y
    Int J Surg; 2024 Jun; 110(6):3536-3542. PubMed ID: 38445489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
    Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
    Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study.
    Kaaki B; Gupta D
    PLoS One; 2020; 15(7):e0235961. PubMed ID: 32645082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of overactive bladder: percutaneous tibial nerve stimulation, sacral nerve stimulation, or botulinum toxin?
    Tubaro A; Puccini F; De Nunzio C
    Curr Opin Urol; 2015 Jul; 25(4):305-10. PubMed ID: 26049873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sacral Neuromodulation for Genitourinary Problems.
    Banakhar M; Hassouna M
    Prog Neurol Surg; 2015; 29():192-9. PubMed ID: 26394134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment.
    Hoag N; Plagakis S; Pillay S; Edwards AW; Gani J
    Neurourol Urodyn; 2017 Jun; 36(5):1377-1381. PubMed ID: 27612039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensing in Sacral Neuromodulation: A Feasibility Study in Subjects With Urinary Incontinence and Retention.
    Goudelocke C; Jungbauer Nikolas LM; Bittner KC; Offutt SJ; Miller AE; Slopsema JP
    Neuromodulation; 2024 Feb; 27(2):392-398. PubMed ID: 37589643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience.
    Chartier-Kastler E
    BJU Int; 2008 Feb; 101(4):417-23. PubMed ID: 18070181
    [No Abstract]   [Full Text] [Related]  

  • 36. Refractory overactive bladder after urethrolysis for bladder outlet obstruction: management with sacral neuromodulation.
    Starkman JS; Duffy JW; Wolter CE; Kaufman MR; Scarpero HM; Dmochowski RR
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Feb; 19(2):277-82. PubMed ID: 17671752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sacral neuromodulation effects on periurethral sensation and urethral sphincter activity.
    Gleason JL; Kenton K; Greer WJ; Ramm O; Szychowski JM; Wilson T; Richter HE
    Neurourol Urodyn; 2013 Jun; 32(5):476-9. PubMed ID: 23168535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction.
    Andretta E; Simeone C; Ostardo E; Pastorello M; Zuliani C
    J Neurol Sci; 2014 Dec; 347(1-2):257-61. PubMed ID: 25454644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
    Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects.
    Tilborghs S; De Wachter S
    Expert Rev Med Devices; 2022 Feb; 19(2):161-187. PubMed ID: 35061951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.